ScreenerHero

NIKI Niki BioSolutions, Inc.

NAS · US · Healthcare · Biotechnology · aptorumgroup.com
4.650USD-6.24%Mkt Cap: 14.50M $P/E: —

Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and inf…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap14.50M USD
Enterprise Value-3.64M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-1.36M USD
Revenue/Share—
Last Price4.650 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.19
EPS (TTM)-2.90
EPS (Forward)—
52W Range
4.5201% of range25.90
52W High25.90 USD
52W Low4.520 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-5.89%
ROA-7.29%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.84M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-11.83%
Net Debt1.67M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.15
Current Ratio0.45
Quick Ratio0.41
Book Value/Sh26.75 USD
Cash/Share2.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 20, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.94M
Float—
Insiders47.50%
Institutions0.28%
Short Interest
Short Ratio0.1d
Short % Float2.24%
Short % Out.1.61%
Shares Short13.11K
Short (prev mo.)4.32K
Technical
SMA 507.044 (-34.0%)
SMA 2008.502 (-45.3%)
Beta-1.00
S&P 52W Chg15.78%
Avg Vol (30d)176.78K
Avg Vol (10d)22.26K
Technical Indicators
RSI (14)34.7
MACD-0.6600
MACD Signal-0.7574
MACD Hist.+0.0975
BB Upper6.230 USD
BB Middle5.107 USD
BB Lower3.984 USD
BB Width43.97%
ATR (14)0.5156 USD
Vol Ratio (20d)0.02x